Progesterone Treatment of Adult Male Rats Suppresses Arginine Vasopressin Expression in the Bed Nucleus of the Stria Terminalis and the Centromedial Amygdala
- 20 December 2005
- journal article
- Published by Wiley in Journal of Neuroendocrinology
- Vol. 18 (3) , 187-194
- https://doi.org/10.1111/j.1365-2826.2005.01400.x
Abstract
The steroid sensitive vasopressin cells of the bed nucleus of the stria terminalis (BST) and centromedial amygdala (CMA) are involved in numerous behavioural and physiological functions. These cells are known to be greatly influenced by gonadal steroids. Castration reduces and testosterone replacement restores arginine vasopressin (AVP)-immunoreactive (-ir) labelling and AVP mRNA expression in the BST and CMA. Gonadal steroids appear to act directly in AVP-expressing cells within the BST and CMA, because the majority of AVP-ir cells in these areas contain oestrogen and androgen receptor immunoreactivity. Recently, we have localised progestin receptor immunoreactivity in virtually all of the AVP-ir cells in the BST and CMA. To understand the role played by progestin receptors in AVP cells within the BST and CMA, we treated male rats with 1 mg of progesterone or oil for 5 days, and then examined AVP immunoreactivity within the brain. We found that progesterone decreased AVP-ir labelling within the BST and CMA, as well as in two of the projection sites of these cells, the lateral septum and lateral habenula. Progesterone treatment did not alter testosterone secretion from the testes, nor did it alter adult male sexual behaviour. These data illustrate an additional mechanism by which the AVP cells in the BST and CMA can be regulated. These data also suggest that progesterone may act in the male brain to influence behaviours that are AVP-dependent.Keywords
This publication has 72 references indexed in Scilit:
- Effects of paradoxical sleep deprivation and cocaine on genital reflexes in hyperlipidic-fed ratsPharmacology Biochemistry and Behavior, 2005
- Neuropeptide systems as novel therapeutic targets for depression and anxiety disordersTrends in Pharmacological Sciences, 2003
- Neuropeptides and Anxiety-Related Behavior.Endocrine Journal, 2001
- Androgen and Estrogen Effects on Vasopressin Messenger RNA Expression in the Medial Amygdaloid Nucleus in Male and Female RatsJournal of Neuroendocrinology, 1995
- Effects of Progesterone and Dihydrotestosterone on Stimulation of Androgen-Dependent Sex Behavior, Accessory Sex Structures, and in Vitro Binding Characteristics of Cytosolic Androgen Receptors in Male Whiptail Lizards (Cnemidophorus inornatus)Hormones and Behavior, 1993
- Expression of the Oxytocin and Vasopressin GenesJournal of Neuroendocrinology, 1992
- Sex differences in hormonal responses of vasopressin pathways in the rat brainJournal of Neurobiology, 1990
- Sequence analysis of the promoter region of the rat vasopressin geneFEBS Letters, 1990
- The vasopressinergic innervation of the brain in normal and castrated ratsJournal of Comparative Neurology, 1985
- Ontogeny of the vasopressinergic neurons of the suprachiasmatic nucleus and their extrahypothalamic projections in the rat brain—presence of a sex difference in the lateral septumBrain Research, 1981